These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31445426)

  • 21. Safety of proton pump inhibitors and risk of gastric cancers: review of literature and pathophysiological mechanisms.
    Ko Y; Tang J; Sanagapalli S; Kim BS; Leong RW
    Expert Opin Drug Saf; 2016 Jan; 15(1):53-63. PubMed ID: 26560097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of gastric cancer, gastrointestinal cancers and other cancers: a comparison of treatment with pantoprazole and other proton pump inhibitors.
    Schneider JL; Kolitsopoulos F; Corley DA
    Aliment Pharmacol Ther; 2016 Jan; 43(1):73-82. PubMed ID: 26541643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increasing prevalence of adenocarcinoma of the oesophagus and gastro-oesophageal junction: a study of the Swedish population between 1970 and 1997.
    Walther C; Zilling T; Perfekt R; Möller T
    Eur J Surg; 2001 Oct; 167(10):748-57. PubMed ID: 11775726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GASTRIC FUNDIC GLAND POLYPS: CAN HISTOLOGY BE USEFUL TO PREDICT PROTON PUMP INHIBITORS USE?
    Brito HLF; Barros C; Freire MV; Silva Filho MND; Nascimento TV
    Arq Gastroenterol; 2018; 55(4):380-384. PubMed ID: 30785522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proton pump inhibitors reduce breast cancer risk in gastric ulcer patients: A population-based cohort study.
    Ding DC; Sung FC; Chen W; Wang JH; Lin SZ
    Breast J; 2020 Mar; 26(3):474-478. PubMed ID: 31478297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of 5α-reductase inhibitors and survival of oesophageal and gastric cancer in a nationwide Swedish cohort study.
    Rabbani S; Mattsson F; Lagergren J; Xie S
    Acta Oncol; 2023 May; 62(5):438-443. PubMed ID: 37216488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meta-analyses: does long-term PPI use increase the risk of gastric premalignant lesions?
    Eslami L; Nasseri-Moghaddam S
    Arch Iran Med; 2013 Aug; 16(8):449-58. PubMed ID: 23906249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased incidence and survival for oesophageal cancer but not for gastric cardia cancer in the Netherlands.
    Dikken JL; Lemmens VE; Wouters MW; Wijnhoven BP; Siersema PD; Nieuwenhuijzen GA; van Sandick JW; Cats A; Verheij M; Coebergh JW; van de Velde CJ
    Eur J Cancer; 2012 Jul; 48(11):1624-32. PubMed ID: 22317953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Temporal trends of Barrett's oesophagus and gastro-oesophageal reflux and related oesophageal cancer over a 10-year period in England and Wales and associated proton pump inhibitor and H2RA prescriptions: a GPRD study.
    Alexandropoulou K; van Vlymen J; Reid F; Poullis A; Kang JY
    Eur J Gastroenterol Hepatol; 2013 Jan; 25(1):15-21. PubMed ID: 23022985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acid suppression medications reduce risk of oesophageal adenocarcinoma in Barrett's oesophagus: a nested case-control study in US male veterans.
    Tan MC; El-Serag HB; Yu X; Thrift AP
    Aliment Pharmacol Ther; 2018 Aug; 48(4):469-477. PubMed ID: 29956826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trends in incidence of oesophageal and gastric cancer according to morphology and anatomical location, in Switzerland 1982-2011.
    Feller A; Fehr M; Bordoni A; Bouchardy C; Frick H; Mousavi M; Steiner A; Arndt V; Clough-Gorr KM;
    Swiss Med Wkly; 2015; 145():w14245. PubMed ID: 26661828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systematic review: the effects of long-term proton pump inhibitor use on serum gastrin levels and gastric histology.
    Lundell L; Vieth M; Gibson F; Nagy P; Kahrilas PJ
    Aliment Pharmacol Ther; 2015 Sep; 42(6):649-63. PubMed ID: 26177572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proton pump inhibitor use represents an independent risk factor for myocardial infarction.
    Shih CJ; Chen YT; Ou SM; Li SY; Chen TJ; Wang SJ
    Int J Cardiol; 2014 Nov; 177(1):292-7. PubMed ID: 25499395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between proton pump inhibitor use and the risk of pancreatic cancer: A Korean nationwide cohort study.
    Hwang IC; Chang J; Park SM
    PLoS One; 2018; 13(9):e0203918. PubMed ID: 30208110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of gastric and oesophageal adenocarcinoma following discontinuation of long-term proton-pump inhibitor therapy.
    Holmberg D; Lagergren J
    J Gastroenterol; 2023 Feb; 58(2):183. PubMed ID: 36515731
    [No Abstract]   [Full Text] [Related]  

  • 36. Maintenance use of non-steroidal anti-inflammatory drugs and risk of gastrointestinal cancer in a nationwide population-based cohort study in Sweden.
    Brusselaers N; Lagergren J
    BMJ Open; 2018 Jul; 8(7):e021869. PubMed ID: 29982219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acid suppressive drugs and gastric cancer: a meta-analysis of observational studies.
    Ahn JS; Eom CS; Jeon CY; Park SM
    World J Gastroenterol; 2013 Apr; 19(16):2560-8. PubMed ID: 23674860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Review article: potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors.
    Laine L; Ahnen D; McClain C; Solcia E; Walsh JH
    Aliment Pharmacol Ther; 2000 Jun; 14(6):651-68. PubMed ID: 10848649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral disease and risk of oesophageal and gastric cancer in a nationwide nested case-control study in Sweden.
    Ljung R; Martin L; Lagergren J
    Eur J Cancer; 2011 Sep; 47(14):2128-32. PubMed ID: 21489778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Continuous treatment of Barrett's oesophagus patients with proton pump inhibitors up to 13 years: observations on regression and cancer incidence.
    Cooper BT; Chapman W; Neumann CS; Gearty JC
    Aliment Pharmacol Ther; 2006 Mar; 23(6):727-33. PubMed ID: 16556174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.